Genscript Biotech (OTCMKTS:GNNSF) Shares Down 1.6% – Here’s Why

Shares of Genscript Biotech Co. (OTCMKTS:GNNSF) were down 1.6% during mid-day trading on Thursday . The company traded as low as C$1.23 and last traded at C$1.23. Approximately 2,500 shares were traded during trading, a decline of 95% from the average daily volume of 54,721 shares. The stock had previously closed at C$1.25.

Genscript Biotech Price Performance

The company’s 50 day moving average is C$1.36 and its 200 day moving average is C$1.38.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.